Dermatology · Charlotte, NC
NPI
1831148485
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
5815 Blakeney Park Dr Ste 100
Charlotte, NC, 28277
Phone (704) 542-2220
Groups this clinician bills Medicare through
Medicare paid, 2024
$593K
12,207 services
Medicare patients, 2024
1,433
Average age 75
Drug cost, 2024
$1.2M
2,172 prescriptions
Company payments, 2025
$73K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Patrick S McElgunn was code 17003 (destruction skin lesion), 4,766 times for 617 patients. In total Patrick S McElgunn billed 12,207 services in 67 codes, and Medicare paid $593K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 4,766 | 617 | $4.58 | $22K |
| 99213 Office E&M - Established | Office | 2,125 | 1,181 | $57.20 | $122K |
| 17000 Destruction Skin Lesion | Office | 1,193 | 771 | $38.27 | $46K |
| 77280 Radiation Treatment Planning | Office | 606 | 30 | $205.17 | $124K |
| G6001 Ultrasonic guidance for placement of radiation therapy fields | Office | 589 | 29 | $138.10 | $81K |
| 77401 Conventional Radiation Treatment | Office | 582 | 30 | $31.66 | $18K |
| 17110 Destruction Skin Lesion | Office | 438 | 361 | $78.21 | $34K |
| 11102 Skin Biopsy | Office | 314 | 278 | $60.26 | $19K |
| 99212 Office E&M - Established | Office | 232 | 162 | $36.80 | $8,538 |
| 99214 Office E&M - Established | Office | 218 | 128 | $89.00 | $19K |
| 99203 Office E&M - New | Office | 200 | 200 | $62.14 | $12K |
| 77427 Conventional Radiation Treatment | Office | 82 | 30 | $149.64 | $12K |
| 96372 Injection Administration | Office | 69 | 16 | $9.90 | $683 |
| 11103 Skin Biopsy | Office | 61 | 49 | $35.64 | $2,174 |
| 17004 Destruction Skin Lesion | Office | 57 | 48 | $114.03 | $6,500 |
By year: 2022 $351K for 9,170 services; 2023 $459K for 9,966 services; 2024 $593K for 12,207 services.
Medicare prescription drug claims, 2024
In 2024, the drug Patrick S McElgunn prescribed most often to Medicare patients was Mupirocin, with 320 prescriptions and refills. In total Patrick S McElgunn wrote 2,172 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mupirocin Generic | 320 | 324 | 250 | $2,143 |
| Ketoconazole Generic | 290 | 331 | 139 | $3,829 |
| Hydrocortisone Generic | 246 | 287 | 170 | $1,849 |
| Betamethasone Dipropionate Generic | 193 | 212 | 104 | $6,563 |
| Doxycycline Hyclate Generic | 177 | 198 | 132 | $6,829 |
| Triamcinolone Acetonide Generic | 132 | 141 | 88 | $1,178 |
| Ciclopirox Ciclopirox Olamine | 110 | 123 | 49 | $1,883 |
| Betamethasone Valerate Generic | 105 | 108 | 62 | $3,100 |
| Metronidazole Generic | 65 | 93 | 30 | $3,015 |
| Clindamycin Phosphate Generic | 46 | 55 | 23 | $1,277 |
| Ciclopirox Generic | 38 | 38 | 23 | $1,426 |
| Valacyclovir Valacyclovir Hcl | 34 | 66 | 18 | $2,272 |
| Prednisone Generic | 29 | 39 | 14 | $159 |
| Dupixent Pen Dupilumab | 26 | 26 | Under 11 | $99K |
| Desonide Generic | 24 | 24 | Under 11 | $646 |
Brand drugs: 204 claims; generic drugs: 1,968 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Patrick S McElgunn $73K ($73K in general payments such as food, travel and fees) from 22 companies. The largest payer was Galderma Laboratories, L.P. with $15K.
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. GALD.SW | 13 | $15K |
| Pfizer Inc. PFE | 20 | $15K |
| UCB, Inc. UCB.BR | 29 | $14K |
| Botanix SB Inc | 9 | $7,784 |
| Regeneron Healthcare Solutions, Inc. REGN | 14 | $7,482 |
| Genzyme Corporation SNY | 4 | $6,377 |
| Abbvie Inc. ABBV | 16 | $6,318 |
| Journey Medical Corporation DERM | 3 | $1,213 |
| Medimetriks Pharmaceuticals, Inc. | 6 | $192 |
| Janssen Biotech, Inc. JNJ | 1 | $89.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.